| 摘要 |
The present invention relates to a methoxychromenylchalcone or a methoxychromenylphenylpropenone derivative and an use of the same as an anti-cancer agent and, more specifically, to an anti-cancer pharmaceutical composition having an anti-cancer effect through an inhibitory effect on G1 cell cycle progression in colon cancer cells of a methoxychromenylchalcone or a methoxychromenylphenylpropenone derivative. |
